What question did this study set out to answer?

The study aims to describe the clinical presentation and treatment responses of recombinant growth hormone in girls with Turner syndrome.

Clinical Profile and Response to Recombinant Growth Hormone in Girls with Turner Syndrome: Experience from a Tertiary Care Centre in North India

View Full Paper

Ask AI

Bookmark

Authors

Retrospective study analyzes growth hormone effects on height in Indian girls with Turner syndrome, highlighting rapid improvement.

The study aims to describe the clinical presentation and treatment responses of recombinant growth hormone in girls with Turner syndrome.
Retrospective analysis of clinical data from 33 girls with Turner syndrome
Assessment of auxological data before and after recombinant growth hormone therapy
Documentation of comorbidities and treatment history
Mean age at presentation was 9.8 years with 100% presenting with short stature
48.5% of patients received recombinant growth hormone therapy
Significant improvements in height standard deviation scores from -0.7 to 0.19
Predicted adult height increased from 142.2 cm to 147.4 cm over 16 months of therapy
Strong correlation between height gain and duration of recombinant growth hormone therapy (r = 0.967)

Nanda et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark